Relivion MG App

The Relivion MG App is an optional smartphone interface for reviewing information from the Relivion migraine treatment device. It displays device status, indications and alerts, and allows…

Registry build 21.09.26

The Relivion MG App is an optional smartphone interface for reviewing information from the Relivion migraine treatment device. It displays device status, indications and alerts, and allows patients to report their migraine headache status for follow-up.

The app communicates with the headset over a low-energy Bluetooth connection. Treatment and device information can pass through the mobile application to the optional physician interface, enabling remote review of migraine attacks and treatments performed.

Listed Item

An application software program intended to extract, process, and store non-clinical processing data (e.g., log of equipment usage, equipment status) from medical equipment to assist process management. It is not intended for control of equipment

Patient Management

The app and physician interface form the system’s optional Patient Management Interface. Treatment activation and stimulation intensity are controlled using the headset’s own controls. The app supports information review and reporting within the prescribed home-use system for adults.

3manufacturers in China registered for this device type
1catalogue number
2510(k) clearances naming this product code

Who Else Makes It

Concentrated in Guangdong (2), Zhejiang (1). One is registered as a contract manufacturer, able to build to a specification.

Chinese manufacturers registered for FDA product code PCC
Manufacturer City Province Registered as Device types
JDI Electronics Factory Dongguan Guangdong Contract manufacturer 7
Shenzhen Dongdixin Technology Co., Ltd. Shenzhen Guangdong Contract manufacturer 18
WAT Medical Technology Inc. Ningbo Zhejiang Repacker / relabeller 4

Record

Regulatory record for Relivion MG App
Listed by Neurolief Inc., United States
FDA product code PCC
Device type Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device class Class 2
Regulation 21 CFR 882.5891
Establishment Complaint-file establishment, Manufacturer, Exporter
510(k) K212106
Record published 2021-12-19
Record revised 2026-01-09 (version 3)

Specifications

Specifications
MRI safety Labeling does not contain MRI Safety Information
Prescription Prescription only
Label carries lot or batch number, manufacturing date

Catalogue Numbers

Catalogue numbers for Relivion MG App
Catalogue number Size Status
RLV-PMI-102 In distribution

Same Product Code

Other products under the same FDA product code
Product Sold by Catalogue numbers
Cefaly® Cefaly Technology Sprl 14
HeadaTerm WAT Medical Technology Inc. 3
Relivion Neurolief Inc. 2
Allive NU Eyne Co., Ltd. 1
Elexir NU Eyne Co., Ltd. 1
Tens 7000 Drive DeVilbiss Healthcare 1
Doopang Ybrain Inc. 1
Relivion MG PMI Physician Interface Neurolief Inc. 1
Enso Hinge Health Inc. 1
AccuRelief Drive DeVilbiss Healthcare 1
Elexir 2.0 NU Eyne Co., Ltd. 1

510(K) Clearances

FDA 510(k) clearances naming this product code
Clearance Decision date
K212106 2021-08-02
K203419 2021-02-16

Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.

Where China Actually Supplies

Every device page names the company that lists it and the factories registered to make the same thing. These are the sections with the most of them.

5,100manufacturers registered in China
2,581device types they are registered for
340,248device records, each naming its maker
31provinces with a registered manufacturer